Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Judicial Panel for Multidistrict Litigation Consolidates Paraquat Claims

On June 7, 2021, the Judicial Panel for Multidistrict Litigation consolidated Paraquat claims into the Southern District of Illinois. This consolidation was only for the federally filed paraquat cases.

Paraquat is an herbicide made to defoliate entire crops. It has been used since 1964 and has not been approved for residential use. One of the side effects of Paraquat poisoning is a diagnosis of Parkinson’s disease. There are two main types of claims: exposure and applicator claims.

Currently, the consolidation of Paraquat is ongoing with many new cases being compiled in the Southern District of Illinois.

There have been many studies that have linked Paraquat to Parkinson’s disease.

For example, a 2018 research study from the University of Guelph found “low level of exposure to pesticides like paraquat and maneb disrupted cells in a way that mimicked the effects of mutations known to cause PD. Those at genetic risk for the disease were more vulnerable to such effects.” [1]

Later, in 2019, researchers found that the occurrence of Parkinson’s disease was 25% higher in participants exposed to Paraquat and that those who were exposed to Paraquat for longer periods of time had a higher frequency of Parkinson’s disease.

If you or a loved one has been injured by Paraquat, or have developed Parkinson’s disease due to the exposure of Paraquat or the application of it, please call us at the Michael Brady Lynch firm. Our number is 888-585-5970. We have attorneys standing by to answer your call!

[1] Paraquat Multidistrict Litigation https://newyork.legalexaminer.com/legal/paraquat-mdl-grows-as-another-plaintiff-blames-the-herbicide-for-parkinsons-disease/

 

 

Injured on a Cruise Ship? Call Us

Injured on a Cruise Ship? Call Us

Cruise vacations promise relaxation and adventure, but accidents do happen. Injuries aboard cruise ships can range from minor incidents to severe accidents, raising complicated legal questions about liability and compensation.

read more
Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

According to the National Center for Biotechnology Medicine, more people die from drug overdoses in the US than any other form of accidental death. Opioid overdoses outnumber the historical peak death rate of HIV, gun violence, and car crashes. There’s no doubt we’re in the middle of an opioid crisis. Often, people become addicted to this drug after a legitimate prescription to manage pain after surgery or a chronic pain condition.

read more
Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Over the past 20 to 30 years, studies and mainstream media outlets have blamed video games for desensitizing minors to violence, increased obesity rates, sedentary lifestyles, and mental health issues like depression and anxiety. Now, developers are facing video game lawsuits from gamers who have become addicted to video games. Learn more about video game addiction and what to do if you or a loved one have suffered from video game addiction below.

read more
Ozempic Lawsuit 2024: The Latest Updates

Ozempic Lawsuit 2024: The Latest Updates

The FDA has approved Ozempic, a medication manufactured by Dutch company Novo Nordisk, for treating type 2 diabetes. Many healthcare providers also prescribe Ozempic to their patients for weight management purposes. This is because the medication’s active ingredient, semaglutide, has been approved for weight loss treatments.

read more
PFAS Lawsuit Update: March 2024

PFAS Lawsuit Update: March 2024

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
×
What Our Clients Are Saying